Calcium phosphate 3.3g oral powder sachets
Calcium phosphate is typically available as an over the counter supplement, antacid, or as an added ingredient in some toothpastes [FDA Label] [L851].
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Calcium phosphate
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Calcium phosphate
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
WHO defined daily dose (DDD)
2 gram
Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.
Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via NHS dm+d BNF mapping files. Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Clinical guidelines and formulary information
British National Formulary
Calcium phosphate
Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.
NICE clinical guidance(11)
Chronic kidney disease: assessment and management (NG203)
Neonatal parenteral nutrition (NG154)
Etelcalcetide for treating secondary hyperparathyroidism (TA448)
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (TA117)
Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132)
Renal and ureteric stones: assessment and management (NG118)
Burosumab for treating X-linked hypophosphataemia in adults (TA993)
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32)
Cerebral palsy in under 25s: assessment and management (NG62)
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & product information
Official product databases and supply status monitoring
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
The phosphate ions in calcium phosphate likely react with hydrochloric acid in the stomach to neutralize the pH.
Food interactions
None known
Human targets
33 targets
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
[L851]
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 211 interactions
Proteins and enzymes this drug interacts with in the body
PMID:17555508 PMID:19789209 PMID:21566075 PMID:22114145 PMID:22789683 PMID:23966241 PMID:25104082 PMID:25292184 PMID:25766501 PMID:26386835 PMID:32817431 PMID:33603117 PMID:34194040 PMID:34467854 PMID:7759551 PMID:8636323 PMID:8702647 PMID:8878438
Senses fluctuations in the circulating calcium concentration: activated by elevated circulating calcium, leading to decreased parathyroid hormone (PTH) secretion in parathyroid glands (By similarity). In kidneys, acts as a key regulator of renal tubular calcium resorption (By similarity). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G-proteins) and modulates the activity of downstream effectors .
PMID:38632411
CASR is coupled with different G(q)/G(11), G(i)/G(o)- or G(s)-classes of G-proteins depending on the context .
PMID:38632411
In the parathyroid and kidney, CASR signals through G(q)/G(11) and G(i)/G(o) G-proteins: G(q)/G(11) coupling activates phospholipase C-beta, releasing diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) second messengers, while G(i)/G(o) coupling mediates inhibition of adenylate cyclase activity .
PMID:38632411 PMID:7759551
The G-protein-coupled receptor activity is activated by a co-agonist mechanism: aromatic amino acids, such as Trp or Phe, act concertedly with divalent cations, such as calcium or magnesium, to achieve full receptor activation .
PMID:27386547 PMID:27434672 PMID:32817431 PMID:33603117 PMID:34194040
Acts as an activator of the NLRP3 inflammasome via G(i)/G(o)-mediated signaling: down-regulation of cyclic AMP (cAMP) relieving NLRP3 inhibition by cAMP .
PMID:32843625
Acts as a regulator of proton-sensing receptor GPR68 in a seesaw manner: CASR-mediated signaling inhibits GPR68 signaling in response to extracellular calcium, while GPR68 inhibits CASR in presence of extracellular protons (By similarity)
PMID:7876246
Interacts with the DNA-binding domain of NR3C1 and mediates its nuclear export .
PMID:11149926
Involved in maternal gene expression regulation. May participate in oocyte maturation via the regulation of calcium homeostasis (By similarity).
Present in the cortical granules of non-activated oocytes, is exocytosed during the cortical reaction in response to oocyte activation and might participate in the block to polyspermy (By similarity)
Plays a role in integrin signaling by negatively regulating alpha-IIb/beta3 activation in thrombin-stimulated megakaryocytes preventing platelet aggregation. Up-regulates PTK2/FAK1 activity, and is also needed for the recruitment of PTK2/FAK1 to focal adhesions; it thus appears to play an important role in focal adhesion formation. Positively regulates cell migration on fibronectin in a CDC42-dependent manner, the effect being negatively regulated by PAK1.
Functions as a negative regulator of stress activated MAP kinase (MAPK) signaling pathways. Down-regulates inositol 1,4,5-trisphosphate receptor-dependent calcium signaling. Involved in sphingosine kinase SPHK1 translocation to the plasma membrane in a N-myristoylation-dependent manner preventing TNF-alpha-induced apoptosis.
Regulates serine/threonine-protein kinase PLK3 activity for proper completion of cell division progression. Plays a role in microtubule (MT) dynamics during neuronal development; disrupts the MT depolymerization activity of STMN2 attenuating NGF-induced neurite outgrowth and the MT reorganization at the edge of lamellipodia. Promotes cardiomyocyte hypertrophy via activation of the calcineurin/NFAT signaling pathway.
Stimulates calcineurin PPP3R1 activity by mediating its anchoring to the sarcolemma. In ischemia-induced (pathological or adaptive) angiogenesis, stimulates endothelial cell proliferation, migration and microvessel formation by activating the PAK1 and ERK1/ERK2 signaling pathway. Also promotes cancer cell survival and proliferation.
May regulate cell cycle and differentiation of spermatogenic germ cells, and/or differentiation of supporting Sertoli cells. Forms a complex with TMC6/EVER1 and TMC8/EVER2 in lymphocytes and keratynocytes where CIB1 stabilizes TMC6 and TMC8 levels and reciprocally PMID:30068544 PMID:32917726
PMID:20691033 PMID:25667979
Involved in ER-Golgi transport by promoting the association between PDCD6IP and TSG101, thereby bridging together the ESCRT-III and ESCRT-I complexes .
PMID:19520058
Together with PEF1, acts as a calcium-dependent adapter for the BCR(KLHL12) complex, a complex involved in ER-Golgi transport by regulating the size of COPII coats .
PMID:27716508
In response to cytosolic calcium increase, the heterodimer formed with PEF1 interacts with, and bridges together the BCR(KLHL12) complex and SEC31 (SEC31A or SEC31B), promoting monoubiquitination of SEC31 and subsequent collagen export, which is required for neural crest specification .
PMID:27716508
Involved in the regulation of the distribution and function of MCOLN1 in the endosomal pathway .
PMID:19864416
Promotes localization and polymerization of TFG at endoplasmic reticulum exit site .
PMID:27813252
Required for T-cell receptor-, Fas-, and glucocorticoid-induced apoptosis (By similarity). May mediate Ca(2+)-regulated signals along the death pathway: interaction with DAPK1 can accelerate apoptotic cell death by increasing caspase-3 activity .
PMID:16132846
Its role in apoptosis may however be indirect, as suggested by knockout experiments (By similarity).
May inhibit KDR/VEGFR2-dependent angiogenesis; the function involves inhibition of VEGF-induced phosphorylation of the Akt signaling pathway .
PMID:21893193
In case of infection by HIV-1 virus, indirectly inhibits HIV-1 production by affecting viral Gag expression and distribution PMID:27784779
Proteins that transport this drug across cell membranes
PMID:11009570 PMID:16790504 PMID:17494632 PMID:19726692 PMID:7929240 PMID:8041748
May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification .
PMID:11009570
Essential for cell proliferation but this function is independent of its phosphate transporter activity PMID:19726692
PMID:12205090 PMID:15955065 PMID:16790504 PMID:17494632 PMID:22327515 PMID:28722801 PMID:30704756
Plays a critical role in the determination of bone quality and strength by providing phosphate for bone mineralization (By similarity). Required to maintain normal cerebrospinal fluid phosphate levels (By similarity). Mediates phosphate-induced calcification of vascular smooth muscle cells (VCMCs) and can functionally compensate for loss of SLC20A1 in VCMCs (By similarity)
PMID:12324554 PMID:20335586 PMID:26047794 PMID:8327470
The cotransport has a Na(+):Pi stoichiometry of 3:1 and is electrogenic (By similarity)
PMID:11880379
The cotransport has a Na(+):Pi stoichiometry of 2:1 and is electroneutral (By similarity)
PMID:11097838 PMID:11248124 PMID:11278579 PMID:15184369 PMID:23612980 PMID:29258289
Important for normal Ca(2+) ion homeostasis in the body, including bone and skin (By similarity). The channel is activated by low internal calcium level, probably including intracellular calcium store depletion, and the current exhibits an inward rectification .
PMID:15184369
Inactivation includes both a rapid Ca(2+)-dependent and a slower Ca(2+)-calmodulin-dependent mechanism; the latter may be regulated by phosphorylation. In vitro, is slowly inhibited by Mg(2+) in a voltage-independent manner.
Heteromeric assembly with TRPV5 seems to modify channel properties. TRPV5-TRPV6 heteromultimeric concatemers exhibit voltage-dependent gating
PMID:11241183 PMID:1374913 PMID:1476165
Contributes to Ca(2+) transport during excitation-contraction coupling in muscle .
PMID:11241183 PMID:1374913 PMID:1476165
In a first phase, voltage-gated channels mediate the rapid increase of cytoplasmic Ca(2+) levels due to release of Ca(2+) stores from the endoplasmic reticulum .
PMID:11241183 PMID:1374913 PMID:1476165
SLC8A1 mediates the export of Ca(2+) from the cell during the next phase, so that cytoplasmic Ca(2+) levels rapidly return to baseline .
PMID:11241183 PMID:1374913 PMID:1476165
Required for normal embryonic heart development and the onset of heart contractions (By similarity)
PMID:11549322 PMID:18768590
Required for normal Ca(2+) reabsorption in the kidney distal convoluted tubules (By similarity). The channel is activated by low internal calcium level and the current exhibits an inward rectification .
PMID:11549322 PMID:18768590
A Ca(2+)-dependent feedback regulation includes fast channel inactivation and slow current decay (By similarity). Heteromeric assembly with TRPV6 seems to modify channel properties.
TRPV5-TRPV6 heteromultimeric concatemers exhibit voltage-dependent gating (By similarity)
PMID:11741831 PMID:16163667 PMID:18268335 PMID:18650434 PMID:26115329
Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm .
PMID:18268335
Can also mediate the release of Ca(2+) from intracellular stores in neurons, and may thereby promote prolonged Ca(2+) signaling in the brain. Required for normal embryonic development of muscle fibers and skeletal muscle. Required for normal heart morphogenesis, skin development and ossification during embryogenesis (By similarity)
The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development
PMID:10517637 PMID:11959145 PMID:25820328 PMID:27754867 PMID:29425510 PMID:30004384
Also forms functionnal heteromeric channels with PKD1, PKD1L1 and PKD1L3 .
PMID:23212381 PMID:24336289
Pore-forming subunit of a heterotetrameric, non-selective cation channel, formed by PKD1L2 and PKD1L3, that is permeable to sodium, potassium, magnesium and calcium and which may act as a sour taste receptor in gustatory cells; however, its contribution to sour taste perception is unclear in vivo and may be indirect .
PMID:19812697 PMID:23212381
The homomeric and heteromeric channels formed by PKD1L2 and PKD1L3 are activated by low pH and Ca(2+), but opens only when the extracellular pH rises again and after the removal of acid stimulus .
PMID:23212381
Pore-forming subunit of a calcium-permeant ion channel formed by PKD1L2 and PKD1L1 in primary cilia, where it controls cilium calcium concentration, without affecting cytoplasmic calcium concentration, and regulates sonic hedgehog/SHH signaling and GLI2 transcription .
PMID:24336289
The PKD1L1:PKD2L1 complex channel is mechanosensitive only at high pressures and is highly temperature sensitive .
PMID:24336289
Pore-forming subunit of a calcium-permeant ion channel formed by PKD1L2 and PKD1 that produces a transient increase in intracellular calcium concentration upon hypo-osmotic stimulation (200 mOsm) (By similarity). May play a role in the perception of carbonation taste (By similarity). May play a role in the sensory perception of water, via a mechanism that activates the channel in response to dilution of salivary bicarbonate and changes in salivary pH (By similarity)
PMID:12354756 PMID:9395096
May regulate Ca(2+) release by other calcium channels. Calcium channel that mediates Ca(2+)-induced Ca(2+) release from the endoplasmic reticulum in non-muscle cells. Contributes to cellular calcium ion homeostasis (By similarity).
Plays a role in cellular calcium signaling
PMID:19464260 PMID:23212381
Also shows permeability towards NA(1+), K(+) and Mg(2+) .
PMID:23212381
Heterotetrameric complex channel is activated by external low pH and Ca(2+), but opens only when the extracellular pH rises again and after the removal of acid stimulus .
PMID:19464260 PMID:23212381
May act as a sour taste receptor in gustatory cells; however, its contribution to sour taste perception is unclear in vivo and may be indirect PMID:19812697
They are however insensitive to dihydropyridines (DHP)
They are however insensitive to dihydropyridines (DHP)
A particularity of this type of channels is an opening at quite negative potentials, and a voltage-dependent inactivation. T-type channels serve pacemaking functions in both central neurons and cardiac nodal cells and support calcium signaling in secretory cells and vascular smooth muscle. They may also be involved in the modulation of firing patterns of neurons which is important for information processing as well as in cell growth processes.
Gates in voltage ranges similar to, but higher than alpha 1G or alpha 1H
PMID:30343943
They are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1E gives rise to R-type calcium currents. R-type calcium channels belong to the 'high-voltage activated' (HVA) group and are blocked by nickel.
They are however insensitive to dihydropyridines (DHP). Calcium channels containing alpha-1E subunit could be involved in the modulation of firing patterns of neurons which is important for information processing
Proteins that carry this drug through the body
PMID:19021548
Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity).
Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity).
Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli .
PMID:6234017
Does not prevent iron uptake by the bacterial siderophore aerobactin PMID:6234017
ATC A12AA01
ATC A11GB01
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Calcium Phosphate
Matched from: Calcium phosphate
Additional database identifiers
Drugs Product Database (DPD)
293
Drugs Product Database (DPD)
4803
ChemSpider
22864
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1514
GenAtlas
CASR
GeneCards
CASR
GenBank Gene Database
X81086
GenBank Protein Database
599820
Guide to Pharmacology
54
UniProt Accession
CASR_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1455
GenAtlas
CALR
GeneCards
CALR
GenBank Gene Database
M32294
GenBank Protein Database
337487
UniProt Accession
CALR_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:16920
GeneCards
CIB1
UniProt Accession
CIB1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8765
GeneCards
PDCD6
UniProt Accession
PDCD6_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11292
GeneCards
SRI
UniProt Accession
SORCN_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:17433
GeneCards
CHP1
UniProt Accession
CHP1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11219
GenAtlas
SPARC
GeneCards
SPARC
GenBank Gene Database
Y00755
GenBank Protein Database
29462
UniProt Accession
SPRC_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1473
GenAtlas
CANX
GeneCards
CANX
GenBank Gene Database
L10284
GenBank Protein Database
186523
UniProt Accession
CALX_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:3604
GeneCards
FBN2
UniProt Accession
FBN2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10500
GenAtlas
S100B
GeneCards
S100B
GenBank Gene Database
M59488
GenBank Protein Database
337730
UniProt Accession
S100B_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1513
GeneCards
CASQ2
UniProt Accession
CASQ2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:9989
GeneCards
RGN
UniProt Accession
RGN_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:30009
GeneCards
PEF1
UniProt Accession
PEF1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10496
GenAtlas
S100A6
GeneCards
S100A6
GenBank Gene Database
M14300
UniProt Accession
S10A6_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:12022
GeneCards
TPT1
UniProt Accession
TCTP_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:24579
GeneCards
CIB2
UniProt Accession
CIB2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10490
GenAtlas
S100A13
GeneCards
S100A13
GenBank Gene Database
X99920
GenBank Protein Database
1694828
UniProt Accession
S10AD_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1512
GeneCards
CASQ1
UniProt Accession
CASQ1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8043
GeneCards
NUCB1
Guide to Pharmacology
2871
UniProt Accession
NUCB1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8044
GeneCards
NUCB2
UniProt Accession
NUCB2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:18794
GeneCards
FBN3
UniProt Accession
FBN3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:15990
GeneCards
GCA
UniProt Accession
GRAN_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1426
GeneCards
CADPS
UniProt Accession
CAPS1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1445
GeneCards
CALM2
UniProt Accession
CALM2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1449
GeneCards
CALM3
UniProt Accession
CALM3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:20441
GeneCards
S100A16
UniProt Accession
S10AG_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1435
GeneCards
CALB2
UniProt Accession
CALB2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1487
GeneCards
CAPS
UniProt Accession
CAYP1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:16018
GeneCards
CADPS2
UniProt Accession
CAPS2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:20407
GeneCards
CALR3
UniProt Accession
CALR3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:8008
GeneCards
NRXN1
UniProt Accession
NRX1A_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:3953
GeneCards
NCS1
UniProt Accession
NCS1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1442
GeneCards
CALM1
UniProt Accession
CALM1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1445
GeneCards
CALM2
UniProt Accession
CALM2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1449
GeneCards
CALM3
UniProt Accession
CALM3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1434
GeneCards
CALB1
UniProt Accession
CALB1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1436
GeneCards
S100G
GenBank Gene Database
X65869
GenBank Protein Database
29602
UniProt Accession
S100G_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:399
GenAtlas
ALB
GeneCards
ALB
GenBank Gene Database
V00494
GenBank Protein Database
28590
UniProt Accession
ALBU_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10946
GeneCards
SLC20A1
UniProt Accession
S20A1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10947
GeneCards
SLC20A2
UniProt Accession
S20A2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11019
GeneCards
SLC34A1
UniProt Accession
NPT2A_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11020
GeneCards
SLC34A2
Guide to Pharmacology
1136
UniProt Accession
NPT2B_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:20305
GeneCards
SLC34A3
UniProt Accession
NPT2C_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:14006
GeneCards
TRPV6
Guide to Pharmacology
512
UniProt Accession
TRPV6_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:11068
GenAtlas
SLC8A1
GeneCards
SLC8A1
GenBank Gene Database
M91368
GenBank Protein Database
180673
UniProt Accession
NAC1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:3145
GeneCards
TRPV5
Guide to Pharmacology
511
UniProt Accession
TRPV5_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10483
GenAtlas
RYR1
GeneCards
RYR1
GenBank Gene Database
J05200
GenBank Protein Database
337722
UniProt Accession
RYR1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10484
GeneCards
RYR2
Guide to Pharmacology
748
UniProt Accession
RYR2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:9011
GeneCards
PKD2L1
Guide to Pharmacology
505
UniProt Accession
PK2L1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:10485
GeneCards
RYR3
UniProt Accession
RYR3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:21716
GeneCards
PKD1L3
UniProt Accession
PK1L3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:17116
GeneCards
CATSPER1
Guide to Pharmacology
388
UniProt Accession
CTSR1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1390
GenAtlas
CACNA1C
GeneCards
CACNA1C
GenBank Gene Database
M92270
Guide to Pharmacology
529
UniProt Accession
CAC1C_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1391
GenAtlas
CACNA1D
GeneCards
CACNA1D
GenBank Gene Database
M76558
GenBank Protein Database
179764
Guide to Pharmacology
530
UniProt Accession
CAC1D_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1393
GenAtlas
CACNA1F
GeneCards
CACNA1F
GenBank Gene Database
AJ006216
GenBank Protein Database
3183953
Guide to Pharmacology
531
UniProt Accession
CAC1F_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1397
GenAtlas
CACNA1S
GeneCards
CACNA1S
GenBank Gene Database
U30707
GenBank Protein Database
1698403
Guide to Pharmacology
528
UniProt Accession
CAC1S_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1401
GenAtlas
CACNB1
GeneCards
CACNB1
GenBank Gene Database
M92303
GenBank Protein Database
179806
UniProt Accession
CACB1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1402
GenAtlas
CACNB2
GeneCards
CACNB2
GenBank Gene Database
S60415
GenBank Protein Database
300417
UniProt Accession
CACB2_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1403
GenAtlas
CACNB3
GeneCards
CACNB3
GenBank Gene Database
X76555
GenBank Protein Database
435135
UniProt Accession
CACB3_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1404
GenAtlas
CACNB4
GeneCards
CACNB4
GenBank Gene Database
U95020
GenBank Protein Database
2058727
UniProt Accession
CACB4_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1388
GenAtlas
CACNA1A
GeneCards
CACNA1A
GenBank Gene Database
AF004884
GenBank Protein Database
2213913
UniProt Accession
CAC1A_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1388
GenAtlas
CACNA1A
GeneCards
CACNA1A
GenBank Gene Database
AF004884
GenBank Protein Database
2213913
UniProt Accession
CAC1A_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1394
GenAtlas
CACNA1G
GenBank Gene Database
AF134986
GenBank Protein Database
6625659
Guide to Pharmacology
535
UniProt Accession
CAC1G_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1395
GenAtlas
CACNA1H
GeneCards
CACNA1H
GenBank Gene Database
AF051946
GenBank Protein Database
14670397
Guide to Pharmacology
536
UniProt Accession
CAC1H_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1396
GenAtlas
CACNA1I
GeneCards
CACNA1I
GenBank Gene Database
AF129133
GenBank Protein Database
5565888
Guide to Pharmacology
537
UniProt Accession
CAC1I_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:1392
GeneCards
CACNA1E
Guide to Pharmacology
534
UniProt Accession
CAC1E_HUMAN
DrugBank citations
If you use DrugBank data in your research, please cite the following publications: